Dose-dependent anti-inflammatory effect of inhaled mometasone furoate/formoterol in subjects with asthma.

Dose-dependent anti-inflammatory effect of inhaled mometasone furoate/formoterol in subjects with asthma.

OBJECTIVE: A well-controlled study in patients with allergic asthma was warranted to assess dose-dependency between fractional concentration of exhaled nitric oxide (FeNO) and sputum eosinophils to a combination of an inhaled corticosteroid plus a long-acting β2-agonist. We sought to characterize t...

Full description

Bibliographic Details
Main Authors:	Nolte, H, Pavord, I, Backer, V, Spector, S, Shekar, T, Gates, D, Nair, P, Hargreave, F
Format:	Journal article
Language:	English
Published:	2013

Similar Items

Effect of mometasone furoate/formoterol combination therapy on nocturnal awakenings in subjects with persistent asthma
by: Pearlman David, et al.
Published: (2011-11-01)

Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary disease
by: Kosoglou T, et al.
Published: (2013-03-01)

Reduction in asthma deteriorations in subjects with persistent asthma uncontrolled on low-, medium-, or high-dose inhaled corticosteroids: a pooled analysis from three clinical trials using combined mometasone furoate/formoterol
by: Weinstein SF, et al.
Published: (2011-11-01)

Efficacy and safety of mometasone furoate/formoterol combination in patients with bronchial asthma
by: A. V. Emelyanov
Published: (2015-12-01)

Efficacy and safety of medium and high doses of mometasone furoate/formoterol (MF/F) combination treatment in subjects with severe persistent asthma
by: Weinstein Steven F, et al.
Published: (2010-12-01)

Efficacy and onset of action of mometasone furoate/formoterol and fluticasone propionate/salmeterol combination treatment in subjects with persistent asthma
by: Bernstein David I, et al.
Published: (2011-12-01)

Efficacy and safety of combined medium-dose mometasone furoate/formoterol (MF/F) in persistent asthmatics
by: Nathan Robert A, et al.
Published: (2010-11-01)

Non-inferiority efficacy comparison of mometasone furoate/formoterol versus fluticasone propionate/salmeterol combination therapies in subjects with persistent asthma
by: Bernstein David I, et al.
Published: (2010-12-01)

Efficacy and safety characteristics of mometasone furoate/formoterol fumarate fixed-dose combination in subjects with moderate to very severe COPD: findings from pooled analysis of two randomized, 52-week placebo-controlled trials
by: Tashkin DP, et al.
Published: (2012-02-01)

Pharmacokinetics of indacaterol, glycopyrronium and mometasone furoate administered as an inhaled fixed-dose combination in Japanese and Caucasian healthy subjects
by: Satoru Inoue, et al.
Published: (2021-01-01)

Efficacy and safety of a fixed-dose combination of mometasone furoate and formoterol fumarate in subjects with moderate to very severe COPD: results from a 52-week Phase III trial
by: Tashkin DP, et al.
Published: (2012-02-01)

Long-term safety of Mometasone Furoate administered via a dry powder inhaler in children: Results of an open-label study comparing Mometasone Furoate with Beclomethasone Dipropionate in children with persistent asthma
by: Corren Jonathan, et al.
Published: (2009-07-01)

Lung function improvements following inhaled indacaterol/glycopyrronium/mometasone furoate are independent of dosing time in asthma patients: a randomised trial
by: Jutta Beier, et al.
Published: (2021-04-01)

Validated chromatographic methods for the simultaneous determination of Mometasone furoate and Formoterol fumarate dihydrate in a combined dosage form
by: Hanan A. Merey, et al.
Published: (2016-06-01)

Mometasone furoate/formoterol combination therapy increases frequency of days/nights free of short-acting β<sub>2</sub>-agonist use
by: Nayak AS, et al.
Published: (2011-11-01)

Efficacy of Mometasone Furoate and Fluticasone Furoate on Persistent Allergic Rhinoconjunctivitis
by: W. Hamizan Aneeza M.S., et al.
Published: (2013-09-01)

Мometasone furoate/formoterol: new fixed-dose combination in the treatment of bronchial asthma
by: A. V. Еmelyanov
Published: (2013-12-01)

Forced degradation of mometasone furoate and development of two RP-HPLC methods for its determination with formoterol fumarate or salicylic acid
by: Ramzia I. El-Bagary, et al.
Published: (2016-05-01)

Development of simple and fast UV-method for the quantitative determination of mometasone furoate in a large number of metered doses of an aqueous nasal spray of mometasone furoate
by: Mykhaylo Levin, et al.
Published: (2019-11-01)

Development of semisolid pharmaceutical forms with mometasone furoate
by: Rédai Emőke Margit, et al.
Published: (2023-12-01)

New Vehiculation Systems of Mometasone Furoate for the Treatment of Inflammatory Skin Diseases
by: Raquel Taléns-Visconti, et al.
Published: (2022-11-01)

Effectiveness of 0.1% mometasone furoate under hydrocolloid dressing versus 0.1% mometasone furoate in patients with lichen simplex chronicus
by: Hiu Lai Lo, et al.
Published: (2023-08-01)

Nasal Absorption Enhancement of Mometasone Furoate Nanocrystal Dispersions
by: Masuda S, et al.
Published: (2023-10-01)

Mometasone furoate is not superior to saline for chronic rhinitis in the elderly
by: Victor Carvalho, et al.
Published: (2019-10-01)

Mometasone Furoate Improves Nasal and Ocular Symptoms of Seasonal Allergic Rhinitis in Adolescents
by: Robert Anolik M.D., et al.
Published: (2010-01-01)

Cost-Effectiveness of Once-Daily, Single-Inhaler Indacaterol Acetate/ Glycopyrronium Bromide/ Mometasone Furoate in Patients with Uncontrolled Moderate-to-Severe Asthma in Canada
by: Mtibaa M, et al.
Published: (2021-12-01)

Fluticasone furoate: CAPTAIN of fluticasones in type 2 inflammatory asthma
by: Couillard, S, et al.
Published: (2022)

Randomized, Open Label, Active Controlled Comparative Study to Assess Safety, Efficacy of Mometasone & Formoterol Versus Fluticasone & Formoterol Dry Powder Inhaler in Treatment of Mild to Moderate Persistent Asthma
by: Parasuramalu B G, et al.
Published: (2015-06-01)

EFFICACY AND SAFETY OF USING MOMETASONE FUROATE IN CHILDREN WITH ATOPIC DERMATITIS
by: A.Yu. Tomilova, et al.
Published: (2009-08-01)

EFFECTIVENESS OF MOMETASONE FUROATE IN TREATMENT OF PALATINE TONSIL HYPERTROPHY IN CHILDREN
by: E.V. Nosulya, et al.
Published: (2009-05-01)

EFFICACY AND SAFETY OF USING MOMETASONE FUROATE IN CHILDREN WITH ATOPIC DERMATITIS
by: A.Yu. Tomilova, et al.
Published: (2009-08-01)

Efficacy of mometasone furoate nasal spray in the treatment of acute rhinosinusitis
by: Sandeep Shrestha, et al.
Published: (2023-01-01)

Efficacy and Safety Evaluation of Mometasone Furoate in Treating Ocular Inflammation
by: Nayara Almeida Lage, et al.
Published: (2023-01-01)

EFFECTIVENESS OF MOMETASONE FUROATE IN TREATMENT OF PALATINE TONSIL HYPERTROPHY IN CHILDREN
by: E.V. Nosulya, et al.
Published: (2009-01-01)

Comparison of montelukast and mometasone furoate in the prevention of recurrent nasal polyps
by: Erkan Vuralkan, et al.
Published: (2012-02-01)

Assessment of Patient Attitudes About Mometasone Furoate Nasal Spray
by: Leonard M. Fromer, et al.
Published: (2008-01-01)

Suppression of cytokine release by fluticasone furoate vs. mometasone furoate in human nasal tissue ex-vivo.
by: Nan Zhang, et al.
Published: (2014-01-01)

A Patient Preference Study that Evaluated Fluticasone Furoate and Mometasone Furoate Nasal Sprays for Allergic Rhinitis
by: Anahi Yanez M.D., et al.
Published: (2016-10-01)

Mometasone furoate and fluticasone furoate are equally effective in restoring nasal epithelial barrier dysfunction in allergic rhinitis
by: Maria Doulaptsi, et al.
Published: (2021-09-01)

Effect of intranasal mometasone furoate administered in children with coexisting allergic rhinitis and asthma towards asthma attacks and lung function
by: Ellen P. Gandaputra, et al.
Published: (2009-12-01)